XML 18 R6.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2023   29,925,612      
Balance at beginning of period at Dec. 31, 2023 $ 1,274,283 $ 296 $ 374,888 $ 1,061,456 $ (162,357)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income (Loss) (84,140)     (84,140)  
Other comprehensive income, net of tax 1,514       1,514
Stock-based compensation expense 5,032   5,032    
Issuance of common stock under share-based compensation arrangements (in shares)   244,989      
Issuance of common stock under share-based compensation arrangements 0 $ 1 (1)    
Issuance of common stock related to employee stock purchase plan (in shares)   9,881      
Issuance of common stock related to employee stock purchase plan 223   223    
Cash dividends declared (27,453)     (27,453)  
Ending balance (in shares) at Jun. 30, 2024   30,180,482      
Balance at end of period at Jun. 30, 2024 1,169,459 $ 297 380,142 949,863 (160,843)
Beginning balance (in shares) at Mar. 31, 2024   30,185,732      
Balance at beginning of period at Mar. 31, 2024 1,259,413 $ 297 377,334 1,047,550 (165,768)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income (Loss) (83,802)     (83,802)  
Other comprehensive income, net of tax 4,925       4,925
Stock-based compensation expense 2,664   2,664    
Issuance of common stock under share-based compensation arrangements (in shares)   (11,371)      
Issuance of common stock under share-based compensation arrangements 0        
Issuance of common stock related to employee stock purchase plan (in shares)   6,121      
Issuance of common stock related to employee stock purchase plan 144   144    
Cash dividends declared (13,885)     (13,885)  
Ending balance (in shares) at Jun. 30, 2024   30,180,482      
Balance at end of period at Jun. 30, 2024 $ 1,169,459 $ 297 380,142 949,863 (160,843)
Beginning balance (in shares) at Dec. 31, 2024 30,202,003 30,202,003      
Balance at beginning of period at Dec. 31, 2024 $ 1,226,061 $ 298 384,932 982,304 (141,473)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income (Loss) (68,100)     (68,100)  
Other comprehensive income, net of tax 33,108       33,108
Stock-based compensation expense 3,797   3,797    
Issuance of common stock under share-based compensation arrangements (in shares)   153,718      
Issuance of common stock under share-based compensation arrangements 0 $ 2 (2)    
Issuance of common stock related to employee stock purchase plan (in shares)   9,262      
Issuance of common stock related to employee stock purchase plan 200   200    
Cash dividends declared $ (9,999)     (9,999)  
Ending balance (in shares) at Jun. 30, 2025 30,364,983 30,364,983      
Balance at end of period at Jun. 30, 2025 $ 1,185,067 $ 300 388,927 904,205 (108,365)
Beginning balance (in shares) at Mar. 31, 2025   30,368,843      
Balance at beginning of period at Mar. 31, 2025 1,244,891 $ 300 386,535 978,995 (120,939)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income (Loss) (69,775)     (69,775)  
Other comprehensive income, net of tax 12,574       12,574
Stock-based compensation expense 2,273   2,273    
Issuance of common stock under share-based compensation arrangements (in shares)   (9,518)      
Issuance of common stock under share-based compensation arrangements 0        
Issuance of common stock related to employee stock purchase plan (in shares)   5,658      
Issuance of common stock related to employee stock purchase plan 119   119    
Cash dividends declared $ (5,015)     (5,015)  
Ending balance (in shares) at Jun. 30, 2025 30,364,983 30,364,983      
Balance at end of period at Jun. 30, 2025 $ 1,185,067 $ 300 $ 388,927 $ 904,205 $ (108,365)